InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,232.00
(
0.00%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
81.75
(
-0.85%
)
Bitcoin
69,838.09
(
-0.42%
)
Post# of 459553
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

imho

Send PM Follow Ignore
Followers 10
Posts 778
Boards Moderated 0
Alias Born 03/18/2003

imho

Re: JB3729 post# 33826

Tuesday, 11/10/2015 12:00:22 AM

Tuesday, November 10, 2015 12:00:22 AM

Post# of 459553

Yes, this good info from IR mentions the 100-300 patients for Phase 3 -


Great! That is what I was searching for. That is a very profound and bold position the company is taking. If it (current trial) succeeds, and (I imagine the FDA must approve?), this drastically reduces cost and time for getting this drug to market.

IMHO
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Start posting your company's news
Only $200 per official company press release!